These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 3946461)
1. Interactions of the major risk factors for coronary heart disease. Gotto AM Am J Med; 1986 Feb; 80(2A):48-55. PubMed ID: 3946461 [TBL] [Abstract][Full Text] [Related]
2. [Is hypolipemic treatment effective as a preventive measure?]. Rywik S Przegl Lek; 1989; 46(7):619-23. PubMed ID: 2685917 [No Abstract] [Full Text] [Related]
3. Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke: pooled analysis of 10 Japanese cohort studies. Nakamura K; Nakagawa H; Sakurai M; Murakami Y; Irie F; Fujiyoshi A; Okamura T; Miura K; Ueshima H; Cerebrovasc Dis; 2012; 33(5):480-91. PubMed ID: 22517421 [TBL] [Abstract][Full Text] [Related]
4. Treatment of hyperlipidemia. Gotto AM Am J Cardiol; 1986 May; 57(14):11G-16G. PubMed ID: 3521247 [TBL] [Abstract][Full Text] [Related]
6. Natural disease investigation. Atherosclerosis, blood cholesterol, and the environment. Castelli WP Am J Forensic Med Pathol; 1982 Dec; 3(4):323-7. PubMed ID: 7165021 [TBL] [Abstract][Full Text] [Related]
7. NHLBI workshop on the Lipid Research Clinics Coronary Primary Prevention Trial. Arteriosclerosis; 1985; 5(4):397-403. PubMed ID: 3893403 [No Abstract] [Full Text] [Related]
8. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN. J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296 [TBL] [Abstract][Full Text] [Related]
10. Role of risk factor management in progression and regression of coronary and femoral artery atherosclerosis. Glueck CJ Am J Cardiol; 1986 May; 57(14):35G-41G. PubMed ID: 3521250 [TBL] [Abstract][Full Text] [Related]
12. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
14. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis]. Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811 [TBL] [Abstract][Full Text] [Related]
15. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Watts GF; Lewis B; Brunt JN; Lewis ES; Coltart DJ; Smith LD; Mann JI; Swan AV Lancet; 1992 Mar; 339(8793):563-9. PubMed ID: 1347091 [TBL] [Abstract][Full Text] [Related]
16. Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial. Glueck CJ; Gordon DJ; Nelson JJ; Davis CE; Tyroler HA Am J Clin Nutr; 1986 Oct; 44(4):489-500. PubMed ID: 3532756 [TBL] [Abstract][Full Text] [Related]
17. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications. Rifkind BM Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999 [TBL] [Abstract][Full Text] [Related]
18. Primary prevention of coronary heart disease by lowering lipids: results and implications. Levy RI Am Heart J; 1985 Nov; 110(5):1116-22. PubMed ID: 3904377 [TBL] [Abstract][Full Text] [Related]
19. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related]